These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9663845

  • 1. Effects of topical and subconjunctival cidofovir (HPMPC) in an animal model.
    Banker AS, Bergeron-Lynn G, Keefe KS, De Clercq E, Taskintuna I, Freeman WR.
    Curr Eye Res; 1998 Jun; 17(6):560-6. PubMed ID: 9663845
    [Abstract] [Full Text] [Related]

  • 2. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects.
    Taskintuna I, Banker AS, Rao NA, Wiley CA, Flores-Aguilar M, Munguia D, Bergeron-Lynn G, De Clercq E, Keefe K, Freeman WR.
    Exp Eye Res; 1997 May; 64(5):795-806. PubMed ID: 9245910
    [Abstract] [Full Text] [Related]

  • 3. Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes.
    Banker AS, De Clercq E, Taskintuna I, Keefe KS, Bergeron-Lynn G, Freeman WR.
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1233-42. PubMed ID: 9620084
    [Abstract] [Full Text] [Related]

  • 4. Intraocular properties of hexadecyloxypropyl-cyclic-cidofovir in Guinea pigs.
    Lu S, Cheng L, Hostetler KY, Koh HJ, Beadle JR, Davidson MC, Freeman WR.
    J Ocul Pharmacol Ther; 2005 Jun; 21(3):205-9. PubMed ID: 15969637
    [Abstract] [Full Text] [Related]

  • 5. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG, Bartels SP, Gordon YJ.
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [Abstract] [Full Text] [Related]

  • 6. Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model.
    Romanowski EG, Araullo-Cruz T, Gordon YJ.
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):253-7. PubMed ID: 9019458
    [Abstract] [Full Text] [Related]

  • 7. Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis.
    Banker AS, Arevalo JF, Munguia D, Rahhal FM, Ishimoto B, Berry C, De Clercq E, Ochabski R, Taskintuna I, Freeman WR.
    Am J Ophthalmol; 1997 Aug; 124(2):168-80. PubMed ID: 9262540
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Kirsch LS, Arevalo JF, Chavez de la Paz E, Munguia D, de Clercq E, Freeman WR.
    Ophthalmology; 1995 Apr; 102(4):533-42; discussion 542-3. PubMed ID: 7724170
    [Abstract] [Full Text] [Related]

  • 9. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model.
    Gordon YJ, Romanowski EG, Araullo-Cruz T.
    Cornea; 1994 Nov; 13(6):516-20. PubMed ID: 7842711
    [Abstract] [Full Text] [Related]

  • 10. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis.
    Kaufman HE, Varnell ED, Thompson HW.
    Arch Ophthalmol; 1998 Jun; 116(6):777-80. PubMed ID: 9639447
    [Abstract] [Full Text] [Related]

  • 11. Toxicity comparison of intraocular azithromycin with and without a bioadhesive delivery system in rabbit eyes.
    Goecks T, Werner L, Mamalis N, Fuller SR, Jensen M, Kavoussi SC, Hill M, Olson RJ.
    J Cataract Refract Surg; 2012 Jan; 38(1):137-45. PubMed ID: 22078120
    [Abstract] [Full Text] [Related]

  • 12. Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS).
    Taskintuna I, Rahhal FM, Rao NA, Wiley CA, Mueller AJ, Banker AS, De Clercq E, Arevalo JF, Freeman WR.
    Ophthalmology; 1997 Nov; 104(11):1827-36; discussion 1836-7. PubMed ID: 9373113
    [Abstract] [Full Text] [Related]

  • 13. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis.
    Akler ME, Johnson DW, Burman WJ, Johnson SC.
    Ophthalmology; 1998 Apr; 105(4):651-7. PubMed ID: 9544639
    [Abstract] [Full Text] [Related]

  • 14. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
    Cundy KC, Lynch G, Shaw JP, Hitchcock MJ, Lee WA.
    Curr Eye Res; 1996 May; 15(5):569-76. PubMed ID: 8670758
    [Abstract] [Full Text] [Related]

  • 15. The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir.
    Kaneko H, Mori S, Suzuki O, Iida T, Shigeta S, Abe M, Ohno S, Aoki K, Suzutani T.
    Antiviral Res; 2004 Jan; 61(1):63-6. PubMed ID: 14670595
    [Abstract] [Full Text] [Related]

  • 16. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice.
    Smee DF, Bailey KW, Wong MH, Wandersee MK, Sidwell RW.
    J Infect Dis; 2004 Sep 15; 190(6):1132-9. PubMed ID: 15319864
    [Abstract] [Full Text] [Related]

  • 17. The effect of cidofovir on cytomegalovirus-induced hearing loss in a Guinea pig model.
    White DR, Choo DI, Stroup G, Schleiss MR.
    Arch Otolaryngol Head Neck Surg; 2006 Jun 15; 132(6):608-15. PubMed ID: 16785405
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal cidofovir injection for the management of chronic glaucoma in dogs.
    Low MC, Landis ML, Peiffer RL.
    Vet Ophthalmol; 2014 May 15; 17(3):201-6. PubMed ID: 23763487
    [Abstract] [Full Text] [Related]

  • 19. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model.
    Romanowski EG, Yates KA, Teuchner B, Nagl M, Irschick EU, Gordon YJ.
    Invest Ophthalmol Vis Sci; 2006 May 15; 47(5):2021-6. PubMed ID: 16639011
    [Abstract] [Full Text] [Related]

  • 20. A review of topical and intralesional cidofovir.
    Zabawski EJ.
    Dermatol Online J; 2000 Sep 15; 6(1):3. PubMed ID: 11328613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.